PMA - Zeolite (Clinoptilolite) in the Management of Irritable Bowel Syndrome - a Non-Interventional Study.

Wilhelm MosgoellerClaus MussSandra EisenwagenReinhold JagschHarald Vogelsang

Published in: Zeitschrift fur Gastroenterologie (2024)

The treatment duration of 8 weeks was well tolerated by most patients. Under everyday life conditions, PMA-zeolite alleviated the global IBS-related symptoms and raised the quality of life (QOL). The PMA-zeolite, thus, may represent a good adjuvant therapeutic option for patients with irritable bowel syndrome.

Keyphrases

irritable bowel syndrome
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
early stage
combination therapy
patient reported
gestational age